KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

GoodRx Holdings (GDRX) EBT Margin (2019 - 2025)

GoodRx Holdings' EBT Margin history spans 7 years, with the latest figure at 7.29% for Q4 2025.

  • For Q4 2025, EBT Margin rose 154.0% year-over-year to 7.29%; the TTM value through Dec 2025 reached 7.1%, up 312.0%, while the annual FY2025 figure was 7.1%, 312.0% up from the prior year.
  • EBT Margin for Q4 2025 was 7.29% at GoodRx Holdings, up from 3.11% in the prior quarter.
  • Across five years, EBT Margin topped out at 9.64% in Q2 2025 and bottomed at 25.9% in Q3 2023.
  • The 5-year median for EBT Margin is 2.35% (2021), against an average of 0.3%.
  • The largest YoY upside for EBT Margin was 20181bps in 2021 against a maximum downside of -3311bps in 2021.
  • A 5-year view of EBT Margin shows it stood at 2.75% in 2021, then plummeted by -194bps to 2.58% in 2022, then crashed by -386bps to 12.53% in 2023, then surged by 146bps to 5.75% in 2024, then increased by 27bps to 7.29% in 2025.
  • Per Business Quant, the three most recent readings for GDRX's EBT Margin are 7.29% (Q4 2025), 3.11% (Q3 2025), and 9.64% (Q2 2025).